Health Care
EPS Growth shows the relative growth of a company's earnings over the last year.
The rise in total monies receivable for goods / services sold before expenses.
1yr EPS Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1yr Revenue Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The percentage of the share price that a company pays out as dividends over a year.
The percentage change from the previous year in the dividend paid on each share.
Dividend Yield | ![]() |
---|
1yr DPS Growth | ![]() |
---|
The share price as a ratio of revenue per share.
The share price as a ratio of net asset value.
Price Sales Ratio | ![]() |
---|
Price Book Ratio |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In percentage total change in share price over 30 days.
In percentage total change in share price over 3 months.
Price Chg 30d |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Chg 3m |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The Relative Strength Index measures a share price relative to itself and its recent history.
Momentum is an oscillator that measures the rate of price change.
RSI |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Momentum 20 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Operating Margin is profit as a percentage of sales.
Return on capital employed measures the return from invested and borrowed capital.
Operating Margin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
ROCE |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Earnings per share, the company's profitability expressed on a per share basis.
Analysts' estimates of future EPS for the next 2 years.
EPS |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Forecast EPS | ![]() |
---|
Monies produced from sales of goods and services after trade discounts, VAT, etc.
Operating Profit is the profit after deducting operating costs from gross profits.
Turnover |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Operating Profit Loss |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The difference between current assets and current liabilities.
A current asset representing the company's financial liquidity.
Assets |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cash |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The cumulative amount of stocks sold by company directors over 1 year
The cumulative amount of stocks bought by company directors over 1 year
Sells 1y | ![]() |
---|
Buys 1y | ![]() |
---|
The percentage of stockbrokers that rate the company as a Buy
The percentage of stockbrokers that rate the company as a Hold
Brokers Percent Buy |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Brokers Percent Neutral |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Currency | US Dollars |
Share Price | $ 0.40 |
Change Today | $ 0.00 |
% Change | 0.00 % |
52 Week High | $0.54 |
52 Week Low | $0.28 |
Volume | 320,676 |
Shares Issued | 562.65m |
Market Cap | $225.06m |
Beta | 0.02 |
RiskGrade | 224 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 08-Jul-21 | 10-Sep-20 |
Paid | 29-Jul-21 | 02-Oct-20 |
Amount | 4.90¢ | 18.70¢ |
Time | Volume / Share Price |
16:35 | 28 @ $0.40 |
16:35 | 25 @ $0.40 |
16:35 | 3 @ $0.40 |
15:29 | 14 @ $0.40 |
15:29 | 4 @ $0.37 |
CFO | Ahmed El Gebeily |
CFO | Sherif El Zeiny |
You are here: research